Business Wire

ILOS Upsizes Credit Facility to €450 Million With EIG and La Caisse

20.4.2026 09:00:00 CEST | Business Wire | Press Release

Share

ILOS Projects (“ILOS”), a Pan-European Independent Power Producer (IPP) supported by BNP Paribas Asset Management Alts (BNPP AM Alts), today announced the successful upsizing of its structured credit facility with EIG, a leading institutional investor in the global energy and infrastructure sectors, and La Caisse, a global investment group, for a total of €450 million.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260420576932/en/

ILOS Solarpark, Source: ILOS

The increased commitment builds on deployment under the initial €250 million tranche provided by EIG and reflects continued investor support for ILOS’s platform, portfolio quality, and execution capabilities. The expanded facility will support ILOS’ plans to develop and operate more than 2 GW of solar and battery storage capacity across Europe by 2028.

Intended to provide flexible capital for construction equity and the acquisition of ready-to-build assets, the facility is expected to enable ILOS to advance its growth as a Pan-European IPP. ILOS will continue to focus on core markets, including Ireland, the United Kingdom, Italy, and Germany.

“ILOS has delivered significant growth since inception, and this facility increase is a testament to the strength of our platform and strategy,” said Sascha Klos, Chief Commercial Officer at ILOS. “We are proud to extend our relationship with EIG while welcoming La Caisse as a new partner as we continue to scale our portfolio and strengthen our position as a leading European IPP.”

“ILOS has built a platform with a clear focus on disciplined development and execution across key European power markets,” said Rob Johnson, Managing Director of EIG and President & CIO, EIG Credit Management. “The upsizing of this facility reflects the progress the team has made deploying capital under the initial tranche and our continued confidence in ILOS’ strategy, asset base, and management team. This investment is consistent with EIG’s approach seeking to support scalable renewable energy platforms that we believe are well positioned to meet Europe’s growing demand for reliable power infrastructure.”

“This transaction reflects our confidence in the quality of ILOS’s platform and aligns with our focus on high‑quality renewable power assets across Europe,” added Jérôme Marquis, Managing Director and Head of Private Credit, La Caisse. “By supporting the expansion of solar capacity amid rising energy demand, we are directing capital toward essential infrastructure, alongside partners with a strong track record.”

A&O Shearman served as legal advisor and Akereos Capital as structurer and exclusive debt advisor to ILOS, while Milbank acted as legal advisor to EIG and La Caisse.

About ILOS

ILOS is an emerging Independent Power Producer (IPP) dedicated to accelerating the transition towards a low-carbon energy system through the development, construction, and operation of photovoltaic projects across Europe. As a strategic platform of BNP Paribas Asset Management Alts, a global leader in alternative investments with €300 billion of assets under management, and Europe’s leading alternatives asset manager with a strong track record in infrastructure investment and a 60% majority shareholder in ILOS, the company benefits from long-term capital, deep sector expertise, and a disciplined investment approach.

About EIG

EIG is a leading institutional investor in the global energy and infrastructure sectors with $25.4 billion assets under management as of December 31, 2025. EIG specializes in private investments in energy and energy-related infrastructure on a global basis. During its 43-year history, EIG has committed over $53.4 billion to the energy sector through 425 projects or companies in 44 countries on six continents. EIG’s clients include many of the leading pension plans, insurance companies, endowments, foundations and sovereign wealth funds in the U.S., Asia and Europe. EIG is headquartered in Washington, D.C. with offices in Houston, London, Sydney, Rio de Janeiro, Hong Kong and Seoul. For additional information, please visit EIG’s website at www.eigpartners.com.

About La Caisse

At La Caisse, formerly CDPQ, we have invested for 60 years with a dual mandate: generate optimal long-term returns for our 48 depositors, who represent over 6 million Quebecers, and contribute to Québec’s economic development.

As a global investment group, we’re active in the major financial markets, private equity, infrastructure, real estate and private credit. As at December 31, 2025, La Caisse’s net assets totalled CAD 517 billion. For more information, visit lacaisse.com or consult our LinkedIn or Instagram pages.

La Caisse is a registered trademark of Caisse de dépôt et placement du Québec that is protected in Canada and other jurisdictions and licensed for use by its subsidiaries.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260420576932/en/

Contacts

For further information, please contact:

For EIG:
FGS Global
Kelly Kimberly / Brandon Messina
+1 212-687-8080
EIG@fgsglobal.com

For ILOS:
Thao Vo
vo@ilos-energy.com

For La Caisse:
Conrad Harrington
+ 1 514 847-5493
medias@lacaisse.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi ® /Minjuvi ® ) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL30.5.2026 14:00:00 CEST | Press Release

Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP alone as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3. The oral presentation of these data is taking place at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting being held May 29 – June 2, 2026, in Chicago (Abstract #LBA7000. Session: Oral Abstract Session – Hematologic Malignancies – Lymphoma and Chronic Lymphocytic Leukemia. May 30, 4:00 – 7:00 p.m. ET [3:00 – 6:00 p.m.

Fortegra Completes Acquisition by DB Insurance29.5.2026 22:30:00 CEST | Press Release

The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a

SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 22:01:00 CEST | Press Release

Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.

From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press Release

NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under 20 minutes, saving hundreds of hours of engineer time, shrinking MTTR by more than 95%. A global telecommunications firm found NetBrain's context-grounded agents outperformed a stand-alone frontier LLM on a persistent firewall

Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press Release

Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consistent approach to protecting our innovation and our customers,” said Justin Ferguson, SVP and general counsel at Adtran. “We take all claims seriously, but we will not hesitate to defend ourselves when assertions lack merit. Situations like this place unnecessary strain on technology providers and divert resources from advancing networks and services. By advancing our counterclaim

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye